• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本代谢综合征风险评分(JAMRISC)的评估:一种新开发的问卷,用作日本诊断代谢综合征和胰岛素抵抗的筛查工具。

Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan.

作者信息

Tan Ce, Sasagawa Yutaka, Kamo Ken-Ichi, Kukitsu Takehiro, Noda Sayaka, Ishikawa Kazuma, Yamauchi Natsumi, Saikawa Takashi, Noro Takanori, Nakamura Hajime, Takahashi Fumihiko, Sata Fumihiro, Tada Mitsuhiro, Kokai Yasuo

机构信息

Department of General Medicine, Rumoi Municipal Hospital, 2-16-1 Sinonome, Rumoi, 077-0011, Japan.

Center for Medical Education, Sapporo Medical University, Sapporo, 060-8556, Japan.

出版信息

Environ Health Prev Med. 2016 Nov;21(6):470-479. doi: 10.1007/s12199-016-0568-5. Epub 2016 Oct 3.

DOI:10.1007/s12199-016-0568-5
PMID:27699688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5112197/
Abstract

OBJECTIVES

To prevent the onset of lifestyle-related diseases associated with metabolic syndrome (MetS) in Japan, research into the development of a useful screening method is strongly desired. We developed a new screening questionnaire (JAMRISC) utilizing a logistic regression model and evaluated its ability to predict the development of MetS, type 2 diabetes and other lifestyle-related diseases in Japanese populace.

METHODS

JAMRISC questionnaire was sent to 1,850 individuals in Rumoi, a small city in Hokkaido. We received a total of 1,054 valid responses. To maximize the target individuals accurately diagnosed with MetS, logistic regression analysis was used to generate a unique metabolic syndrome score calculation formula as taking into consideration the clinical relevance of each question item as individual coefficients.

RESULTS

The results of our comparative research utilizing both JAMRISC and Finnish Diabetes Risk Score (FINDRISC) questionnaires revealed the usefulness of JAMRISC for its ability to detect risks for MetS, pre-MetS, diabetes, and pre-diabetes. Study of disease risk detection via JAMRISC questionnaire targeting the 4283 residents of Rumoi indicated a high detection rate for pre-MetS (98.8 %), MetS (94.2 %), pre-diabetes (85.1 %) and type 2 diabetes (94.9 %). In addition, JAMRISC was useful not only as a MetS risk score test, but also as a screening tool for diagnosing insulin resistance.

CONCLUSIONS

JAMRISC questionnaire is a useful instrument for the detection of early risk of not only MetS and type 2 diabetes but also insulin resistance.

摘要

目的

为预防日本与代谢综合征(MetS)相关的生活方式相关疾病的发生,强烈需要开展关于开发有效筛查方法的研究。我们利用逻辑回归模型开发了一种新的筛查问卷(JAMRISC),并评估了其预测日本人群中代谢综合征、2型糖尿病及其他生活方式相关疾病发生的能力。

方法

JAMRISC问卷被发送至北海道一个小城市留萌市的1850人。我们共收到1054份有效回复。为了使准确诊断为代谢综合征的目标个体最大化,使用逻辑回归分析生成一个独特的代谢综合征评分计算公式,将每个问题项目的临床相关性作为个体系数考虑在内。

结果

我们使用JAMRISC和芬兰糖尿病风险评分(FINDRISC)问卷进行的对比研究结果显示,JAMRISC对于检测代谢综合征、代谢综合征前期、糖尿病和糖尿病前期风险具有实用性。针对留萌市4283名居民的JAMRISC问卷疾病风险检测研究表明,代谢综合征前期(98.8%)、代谢综合征(94.2%)、糖尿病前期(85.1%)和2型糖尿病(94.9%)的检测率很高。此外,JAMRISC不仅作为代谢综合征风险评分测试有用,而且作为诊断胰岛素抵抗的筛查工具也有用。

结论

JAMRISC问卷是一种不仅可用于检测代谢综合征和2型糖尿病早期风险,还可用于检测胰岛素抵抗早期风险的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0328/5112197/ecdb3ad088a1/12199_2016_568_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0328/5112197/f9ef2825ac3b/12199_2016_568_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0328/5112197/ecdb3ad088a1/12199_2016_568_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0328/5112197/f9ef2825ac3b/12199_2016_568_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0328/5112197/ecdb3ad088a1/12199_2016_568_Fig2_HTML.jpg

相似文献

1
Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan.日本代谢综合征风险评分(JAMRISC)的评估:一种新开发的问卷,用作日本诊断代谢综合征和胰岛素抵抗的筛查工具。
Environ Health Prev Med. 2016 Nov;21(6):470-479. doi: 10.1007/s12199-016-0568-5. Epub 2016 Oct 3.
2
Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.验证芬兰糖尿病风险评分(FINDRISC)问卷在希腊用于筛查未诊断的 2 型糖尿病、糖调节受损和代谢综合征的适用性。
Diabetes Metab. 2011 Apr;37(2):144-51. doi: 10.1016/j.diabet.2010.09.006. Epub 2010 Dec 7.
3
Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.评估芬兰糖尿病风险评分(FINDRISC)作为代谢综合征筛查工具的效果。
Rev Diabet Stud. 2013 Winter;10(4):283-92. doi: 10.1900/RDS.2013.10.283. Epub 2014 Feb 10.
4
Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.颈围作为一种识别代谢综合征和胰岛素抵抗的简单工具:来自巴西代谢综合征研究的结果。
Clin Endocrinol (Oxf). 2013 Jun;78(6):874-81. doi: 10.1111/j.1365-2265.2012.04487.x. Epub 2013 Mar 25.
5
C-Peptide Is a Sensitive Indicator for the Diagnosis of Metabolic Syndrome in Subjects from Central Mexico.C肽是墨西哥中部受试者代谢综合征诊断的敏感指标。
Metab Syndr Relat Disord. 2016 May;14(4):210-6. doi: 10.1089/met.2015.0067. Epub 2016 Feb 10.
6
The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.国家胆固醇教育计划成人治疗组第三次报告(NCEP/ATP III)和国际糖尿病联盟(IDF)的定义在诊断加沙地带巴勒斯坦人代谢综合征(MetS)方面的可靠性。
Diabetes Metab Syndr. 2012 Jan-Mar;6(1):4-8. doi: 10.1016/j.dsx.2012.05.017. Epub 2012 Jun 7.
7
The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.代谢综合征作为预测未来糖尿病的工具:澳大利亚糖尿病、肥胖和生活方式研究(AusDiab研究)
J Intern Med. 2008 Aug;264(2):177-86. doi: 10.1111/j.1365-2796.2008.01935.x. Epub 2008 Feb 20.
8
NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction.采用美国国家胆固醇教育计划成人治疗组第三次报告(NCEP-ATPIII)定义的代谢综合征、2型糖尿病以及性功能障碍男性患者性腺功能减退的患病率。
J Sex Med. 2007 Jul;4(4 Pt 1):1038-45. doi: 10.1111/j.1743-6109.2007.00529.x.
9
Total testosterone is the most valuable indicator of metabolic syndrome among various testosterone values in middle-aged Japanese men.在日本中年男性的各种睾酮值中,总睾酮是代谢综合征最有价值的指标。
Endocr J. 2015;62(2):123-32. doi: 10.1507/endocrj.EJ14-0313. Epub 2014 Oct 23.
10
The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients.糖尿病和非糖尿病患者的代谢综合征、胰岛素抵抗与心血管风险
J Clin Endocrinol Metab. 2005 Oct;90(10):5698-703. doi: 10.1210/jc.2005-0799. Epub 2005 Aug 9.

引用本文的文献

1
Metabolic syndrome index measurement tool (MSI): scale development, reliability and validity study.代谢综合征指数测量工具(MSI):量表开发、信度与效度研究
BMC Public Health. 2025 Jan 6;25(1):51. doi: 10.1186/s12889-025-21304-7.
2
Serum Uric Acid and Iron Status: Exploring a Complex Interaction in Metabolic Syndrome Patients of Eastern India.血清尿酸与铁状态:探索印度东部代谢综合征患者中的复杂相互作用
Cureus. 2024 Oct 4;16(10):e70803. doi: 10.7759/cureus.70803. eCollection 2024 Oct.
3
Non-Laboratory-Based Risk Prediction Tools for Undiagnosed Pre-Diabetes: A Systematic Review.

本文引用的文献

1
Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.评估芬兰糖尿病风险评分(FINDRISC)作为代谢综合征筛查工具的效果。
Rev Diabet Stud. 2013 Winter;10(4):283-92. doi: 10.1900/RDS.2013.10.283. Epub 2014 Feb 10.
2
Insulin resistance and the development of cardiovascular disease in a Japanese community: the Hisayama study.胰岛素抵抗与日本社区心血管疾病的发展:日山研究。
J Atheroscler Thromb. 2012;19(11):977-85. doi: 10.5551/jat.13698. Epub 2012 Jul 14.
3
Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
用于未诊断的糖尿病前期的非基于实验室的风险预测工具:一项系统综述。
Diagnostics (Basel). 2023 Mar 29;13(7):1294. doi: 10.3390/diagnostics13071294.
4
Identifying Glucose Metabolism Status in Nondiabetic Japanese Adults Using Machine Learning Model with Simple Questionnaire.使用具有简单问卷的机器学习模型识别非糖尿病日本成年人的葡萄糖代谢状态。
Comput Math Methods Med. 2022 Sep 9;2022:1026121. doi: 10.1155/2022/1026121. eCollection 2022.
5
Development and Validation of a Simple Risk Model for Predicting Metabolic Syndrome (MetS) in Midlife: A Cohort Study.中年人群代谢综合征(MetS)预测简易风险模型的开发与验证:一项队列研究
Diabetes Metab Syndr Obes. 2022 Apr 6;15:1051-1075. doi: 10.2147/DMSO.S336384. eCollection 2022.
6
Characteristic of FINDRISC Score and Association with Diabetes Development in 6-Year Follow-Up in PURE Poland Cohort Study.FINDRISC 评分特征及其与 PURE 波兰队列研究 6 年随访期间糖尿病发病的关系。
Vasc Health Risk Manag. 2021 Sep 27;17:631-639. doi: 10.2147/VHRM.S321700. eCollection 2021.
7
Metabolic Age, an Index Based on Basal Metabolic Rate, Can Predict Individuals That are High Risk of Developing Metabolic Syndrome.代谢年龄,一个基于基础代谢率的指数,可以预测患有代谢综合征风险较高的个体。
High Blood Press Cardiovasc Prev. 2021 May;28(3):263-270. doi: 10.1007/s40292-021-00441-1. Epub 2021 Mar 5.
8
Validation of a non-laboratorial questionnaire to identify Metabolic Syndrome among a population in central Mexico.用于识别墨西哥中部人群代谢综合征的非实验室问卷的验证
Rev Panam Salud Publica. 2019 Jan 25;43:e9. doi: 10.26633/RPSP.2019.9. eCollection 2019.
FINDRISC 问卷在瑞典初级保健中识别糖耐量受损个体的可行性。一项基于人群的横断面研究。
Diabet Med. 2012 Dec;29(12):1501-5. doi: 10.1111/j.1464-5491.2012.03664.x.
4
[Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].[在西班牙南部人群中验证用于预测2型糖尿病风险的FINDRISC(芬兰糖尿病风险评分)。皮萨拉研究]
Med Clin (Barc). 2012 Apr 14;138(9):371-6. doi: 10.1016/j.medcli.2011.05.025. Epub 2011 Sep 21.
5
Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.验证芬兰糖尿病风险评分(FINDRISC)问卷在希腊用于筛查未诊断的 2 型糖尿病、糖调节受损和代谢综合征的适用性。
Diabetes Metab. 2011 Apr;37(2):144-51. doi: 10.1016/j.diabet.2010.09.006. Epub 2010 Dec 7.
6
Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.胰岛素抵抗与阿尔茨海默病的病理学有关:日山研究。
Neurology. 2010 Aug 31;75(9):764-70. doi: 10.1212/WNL.0b013e3181eee25f. Epub 2010 Aug 25.
7
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.社区动脉粥样硬化风险研究中的代谢综合征与心血管疾病发病的11年风险
Diabetes Care. 2005 Feb;28(2):385-90. doi: 10.2337/diacare.28.2.385.
8
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.新检测出的糖耐量异常:心肌梗死后长期预后的重要预测指标。
Eur Heart J. 2004 Nov;25(22):1990-7. doi: 10.1016/j.ehj.2004.09.021.
9
Hyperinsulinemia and risk of Alzheimer disease.高胰岛素血症与阿尔茨海默病风险
Neurology. 2004 Oct 12;63(7):1187-92. doi: 10.1212/01.wnl.0000140292.04932.87.
10
Impact of body mass index on the risk of total cancer incidence and mortality among middle-aged Japanese: data from a large-scale population-based cohort study--the JPHC study.体重指数对日本中年人群全癌发病率和死亡率风险的影响:来自一项基于大规模人群队列研究——日本公共卫生中心(JPHC)研究的数据。
Cancer Causes Control. 2004 Sep;15(7):671-80. doi: 10.1023/B:CACO.0000036177.77953.47.